Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Servier researchers report three series of FTase inhibitors

Sep. 19, 2002

IST-FS-29 effective in murine tumor models, well tolerated after repeated doses

Sep. 19, 2002

A novel COX-2 inhibitor may increase the antiproliferative effects of lovastatin in colon cancer

Sep. 19, 2002

Phase III Tarceva trial in NSCLC completes enrollment

Sep. 18, 2002

RPR-109881A: pharmacokinetics in patients with advanced solid tumors

Sep. 17, 2002

U. of Texas research group discovers new Src kinase inhibitors

Sep. 16, 2002

Selective or dual kinase inhibitors covered by Ortho-McNeil patent

Sep. 16, 2002

Zoledronic acid effective against bone lesions in prostate cancer in late-stage trial

Sep. 16, 2002

Factor 5A gene induces apoptosis in human cancer cells

Sep. 16, 2002

New FTase inhibitors for cancer and other conditions claimed by Servier

Sep. 13, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Science
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...